RecallDepth
Class III Terminated

Temozolomide capsules, 20 mg, packaged in a) 5-count bottle(NCD 43975-253-05), b) 14-count bottle (NDC 43975-253-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071.

Company
Amerigen Pharmaceuticals Inc.
Recall Initiated
October 5, 2018
Posted
October 24, 2018
Recall Number
D-0249-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
5,232 bottles: a) 4,146 bottles; b) 1,086 bottles
Firm Location
Lyndhurst, NJ, United States

Reason for Recall

Failed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.

Distribution

Product was distributed U.S. nationwide.

Lot / Code Info

Lot #: a) 17F058A, Exp 6/19; b) 17F058B, Exp 6/19

More recalls by Amerigen Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class III Drug recalls